Trusted News Discovery Since 2008
{{/content}}
Bharat Biotech seeks emergency use approval for Covid-19 vaccine Covaxin | Oneindia News
Video Credit: Oneindia
Published on December 8, 2020 - Duration: 01:08s
Bharat Biotech seeks emergency use approval for Covid-19 vaccine Covaxin | Oneindia News
Now after Serum Institute of India and American pharma giant Pfizer, Bharat Biotech, the Hyderabad-based pharmaceutical firm that has been developing coronavirus vaccine Covaxin, has applied to the central drug regulator seeking emergency use authorisation.
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and is currently in Phase 3 trials.
The trials are on at 18 sites across the country with over 22,000 volunteers.
#BharatBiotech #Covaxin #Coronavirus
You are here
Related news from verified sources
Hyderabad-based Bharat Biotech filed an application seeking emergency use authorisation for Covaxin on Monday, becoming the third company to seek such regulatory...
on December 7, 2020 • IndiaTimes
India's subject expert committee that met on Wednesday sought more data relating to the vaccine's immunogenicity, which will mean the emergency-use approval may...
on December 30, 2020 • IndiaTimes
Serum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization.
on December 19, 2020 • DNA
Related videos from verified sources
Covid-19 vaccine dry run to be conducted in all states/UTs on January 2nd| Oneindia News 01:09
Video credit: Oneindia - Published on December 31, 2020
'India will get 50% of everything...': World's largest vaccine-maker, SII 02:53
Video credit: HT Digital Content - Published on December 29, 2020
PM launches National Common Mobility Card, driverless train | Oneindia News 02:34
Video credit: Oneindia - Published on December 28, 2020